Steven Nichtberger

Steven Nichtberger was the founder of Tengion, Inc., founded in 2003, where the titles held included President, Chief Executive Officer & Director from 2004 to 2011.
Dr. Nichtberger is the founder of Cabaletta Bio, Inc., founded in 2017, holding the titles of Chairman, President & Chief Executive Officer since 2017.
Current jobs include Member-Governors Board at Main Line Health, Inc. since 2014, Venture Advisor at Israel Biotech Fund, and Managing Partner at Gbf Advisors LLC.
Former jobs include Chairman & Chief Executive Officer at ControlRad, Inc. from 2012 to 2015; Vice Chairman at Life Sciences Pennsylvania from 2007 to 2014; Director at Biotechnology Innovation Organization from 2010 to 2011; Director at The Biotechnology Greenhouse Corp.
of Southeastern PA; Director at Alliance for Regenerative Medicine from 2009 to 2014; Head-Global Marketing at Merck & Co., Inc. from 1995 to 2003; and Member-Overseas Board at The College of Arts & Sciences from 2008 to 2019.
Education includes undergraduate studies at the University of Pennsylvania and The Wharton School of the University of Pennsylvania, with an undergraduate degree conferred in 1983 at The Wharton School, and a doctorate from the State University of New York at Buffalo.